research use only
Cat.No.: S4059
Chemical Structure
| Molecular Weight | 297.95 | Formula | C5H4FeN6Na2O3 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 13755-38-9 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4] | ||
|
In vitro |
DMSO
: 60 mg/mL
(201.37 mM)
Water : 60 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
guanylate cyclase
|
|---|---|
| In vitro |
Sodium Nitroprusside is a potent vasodilator. Sodium nitroprusside has potent vasodilating effects in arterioles and venules. Sodium Nitroprusside breaks down in circulation to release nitric oxide (NO). NO activates guanylate cyclase in vascular smooth muscle and increases intracellular production of cGMP. The end result is vascular smooth muscle relaxation, which allow vessels to dilate. Sodium nitroprusside decreases the proliferation of vascular smooth muscle cells.
|
| In vivo |
Sodium nitroprusside (5 mg/kg) significantly reduces the intestinal ischemiareperfusion injury as a nitric oxide donor in rats.
|
References |
|
(data from https://clinicaltrials.gov, updated on 2024-12-09)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06424756 | RECRUITING | Healthy |
University of Georgia |
2024-07-01 | PHASE2 |
| NCT02560805 | RECRUITING | Stress Disorders, Post-Traumatic |
Emory University |
2015-10 | PHASE2 |
| NCT05193968 | RECRUITING | Hot Flashes; Menopause; Vasomotor System; Labile |
Mayo Clinic |
2022-02-24 | |
| NCT03318094 | ACTIVE_NOT_RECRUITING | Insulin Resistance; Healthy; Obesity |
Vanderbilt University Medical Center |
2017-10-24 | PHASE1 |
| NCT02966665 | RECRUITING | Chronic Obstructive Pulmonary Disease; Pulmonary Artery Hypertension; Heart Failure; Hypertension |
Russell Richardson |
2008-09 | PHASE1 |
| NCT04986072 | TERMINATED | Schizophrenia; Schizoaffective Disorder |
Beth Israel Deaconess Medical Center |
2022-03-14 | PHASE2 |